Relmada Therapeutics, Inc. RLMD Regulatory Asset
Regulatory Asset at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RegulatoryAssets.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s regulatory asset.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s regulatory asset?
- Relmada Therapeutics, Inc. (RLMD) reported regulatory asset of $2M in Q4 2025.